Study S000555

The Effect of Exenatide on Fasting Bile Acids in Newly Diagnosed Type 2 Diabetes Mellitus Patients, a Pilot Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04303819
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 38
Start: 2020-01-05
Primary completion: 2020-01-28
Lead sponsor: Beijing Chao Yang Hospital
Conditions: Type 2 Diabetes Mellitus in Obese
Interventions: DRUG:Exenatide treatment
Results posted: FALSE

Registered primary outcomes

Plasma total bile acids in fasting state [12 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0010028	The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study. Li B, BMC pharmacology & toxicology	2020	Nonrandomized study	PMID 32539783 DOI	cites ClinicalTrials.gov:NCT04303819; registry reference DERIVED:32539783